Cancer Immunotherapy: Whence and Whither. (2017)
Attributed to:
Large scale lentiviral vector production
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1541-7786.mcr-16-0427
PubMed Identifier: 28356330
Publication URI: http://europepmc.org/abstract/MED/28356330
Type: Journal Article/Review
Volume: 15
Parent Publication: Molecular cancer research : MCR
Issue: 6
ISSN: 1541-7786